|
0
|
|
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.
(linkinghub.elsevier.com)
|
Saluzzo F
…
Cirillo DM
Lancet Infectious Diseases
2026-06-01
|
#amr
#susceptibility
#surveillance
#diagnostics
#tb
|
|
0
|
|
A combined ELISA for infection-induced and vaccine-induced mpox antibodies during the clade Ib outbreak in Rwanda: an observational, cross-sectional, clinical validation study.
(linkinghub.elsevier.com)
|
Clarke J
…
Green CA
Lancet Infectious Diseases
2026-06-01
|
#infection
#vaccination
#serology
#immunology
#diagnostics
|
|
0
|
|
Antimicrobial-Resistant Neisseria gonorrhoeae of Public Health Concern, New South Wales, Australia, 2022-2024.
(wwwnc.cdc.gov)
|
Walker LJ
…
Amin J
Emerging Infectious Diseases
2026-06-01
|
#genomics
#infection
#amr
#surveillance
#diagnostics
|
|
0
|
|
Biomolecular profiling for noninvasive health monitoring.
(nature.com)
|
Kim MJ
…
Gao W
Nature Biotechnology
2026-06-01
|
#metabolomics
#proteomics
#biomarker
#diagnostics
#biosensors
|
|
0
|
|
Detecting unannotated splicing events in short-read RNA-seq with SAMI, a UMI-aware Nextflow pipeline.
(academic.oup.com)
|
Mareschal S
…
Bardel C
Bioinformatics
2026-06-01
|
#transcriptomics
#splicing
#sequencing
#diagnostics
|